Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Participants in Transcription-Replication Conflict and Their Role in Formation and Resolution of R-Loops. | Int J Mol Sci | 2025 | 40725198 | PubTator, text mining | PubMed |
| Peptide Drug: Design and Clinical Applications. | MedComm (2020) | 2025 | 40717901 | PubTator, text mining | PubMed |
| Unlocking the potential: m6A-RNA methylation in severe epidermolysis bullosa simplex. | Biosci Rep | 2025 | 40700032 | PubTator, text mining | PubMed |
| METTL14 induces ferroptosis to inhibit colorectal cancer progression by inhibiting TRIB3 via an m6A-YTHDF2-dependent manner. | J Mol Histol | 2025 | 40691523 | PubTator, text mining | PubMed |
| Unveiling the m⁶A regulatory axis in cigarette smoke-induced carcinogenesis: A landmark analysis in toxicology letters. | Toxicol Lett | 2025 | 40675519 | PubTator, text mining | PubMed |
| Expression of m6A-related factors in pulmonary sarcomatoid carcinoma. | Pathol Res Pract | 2025 | 40651121 | PubTator, text mining | PubMed |
| Decoding m6A RNA methylation in kidney disorders: from molecular insights to therapeutic strategies. | J Transl Med | 2025 | 40640897 | PubTator, text mining | PubMed |
| METTL14 mediates the m6A methylation of miR-29a-3p, thereby activating the MAP2K6 signaling pathway and exacerbating the inflammatory response associated with spinal tuberculosis. | J Orthop Surg Res | 2025 | 40629361 | PubTator, text mining | PubMed |
| Novel landscapes of N6-methyladenosine modification of mitochondrial oxidative stress in organ fibrosis. | Eur J Pharmacol | 2025 | 40609613 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA landscape in the aged mouse hearts. | Front Cardiovasc Med | 2025 | 40606020 | PubTator, text mining | PubMed |
| Pancreatic Cancer-Derived Extracellular Vesicles Enriched with miR-223-5p Promote Skeletal Muscle Wasting Associated with Cachexia. | Adv Sci (Weinh) | 2025 | 40605471 | PubTator, text mining | PubMed |
| Stimuli-responsive smart materials enabled high-performance biosensors for liquid biopsies. | J Nanobiotechnology | 2025 | 40597218 | PubTator, text mining | PubMed |
| The role of m6A regulators mRNA expression in peripheral blood mononuclear cells in chronic hepatitis B: a novel diagnostic and prognostic indicator. | BMC Gastroenterol | 2025 | 40596879 | PubTator, text mining | PubMed |
| LncRNA-Encoded Micropeptides: Expression Validation, Translational Mechanisms, and Roles in Cellular Metabolism. | Int J Mol Sci | 2025 | 40565374 | PubTator, text mining | PubMed |
| METTL14/YTHDF2 m6A Axis Protects Against M2 Macrophage Polarization in Endometriosis by Regulating KLF4 Stability. | Appl Biochem Biotechnol | 2025 | 40549286 | PubTator, text mining | PubMed |
| METTL14-mediated m6A modification of ETV4 inhibits tumor development in colorectal cancer. | Mutat Res | 2025 | 40541038 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified GPX2 impacts cancer cell stemness and TKI resistance through regulating of redox metabolism. | Cell Death Dis | 2025 | 40533443 | PubTator, text mining | PubMed |
| m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p. | NPJ Precis Oncol | 2025 | 40527909 | PubTator, text mining | PubMed |
| RNA Through Time: From the Origin of Life to Therapeutic Frontiers in Transcriptomics and Epitranscriptional Medicine. | Int J Mol Sci | 2025 | 40507776 | PubTator, text mining | PubMed |
| Methyltransferase-like factor 14 pathway and its relationship with pathological stages in patients undergoing surgery for colorectal cancer. | World J Gastrointest Surg | 2025 | 40502510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=16